Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20739218 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed GEM05 for Patients With Multiple Myeloma More Than 65 Years Old
Condition: Multiple Myeloma
Interventions: Drug: Melphalan/Prednisone/Velcade;   Drug: Thalidomide/Prednisone/Velcade

Indicates status has not been verified in more than two years